HETERO

Hetero is the first company in India to launch the generic version of Remdesivir injection, COVIFOR, in India, which is used to treat hospitalization cases of COVID-19. Click here to know more... At Hetero, our every action seeks to inspire human belief in accessibility and affordability of life-saving medicines across the world.

Also known as: Hetero Australia Pty, Hetero Drugs Limited, Hetero Europe S.L., Hetero Group, Hetero Kenya Limited, Hetero Labs Limited, Hetero Labs Nigeria Ltd, Hetero Pharma (Beijing) Co. Limited, Hetero Pharma Russia LLC, Hetero Singapore Pte Ltd, Hetero USA Inc.

Primary location: Kiev Ukraine